Copyright Reports & Markets. All rights reserved.

Global Inhaler Corticosteroid Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Inhaler Corticosteroid Device
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Inhaler Corticosteroid Device Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Beclomethasone Dipropionate
    • 1.3.3 Budesonide
    • 1.3.4 Fluticasone Inhaler Powder
    • 1.3.5 Mometasone
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Inhaler Corticosteroid Device Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals and Clinics
    • 1.4.3 Academic and Research Institutes
  • 1.5 Global Inhaler Corticosteroid Device Market Size & Forecast
    • 1.5.1 Global Inhaler Corticosteroid Device Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Inhaler Corticosteroid Device Sales Quantity (2018-2029)
    • 1.5.3 Global Inhaler Corticosteroid Device Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Pfizer Inc.
    • 2.1.1 Pfizer Inc. Details
    • 2.1.2 Pfizer Inc. Major Business
    • 2.1.3 Pfizer Inc. Inhaler Corticosteroid Device Product and Services
    • 2.1.4 Pfizer Inc. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Inc. Recent Developments/Updates
  • 2.2 GlaxoSmithKline Plc
    • 2.2.1 GlaxoSmithKline Plc Details
    • 2.2.2 GlaxoSmithKline Plc Major Business
    • 2.2.3 GlaxoSmithKline Plc Inhaler Corticosteroid Device Product and Services
    • 2.2.4 GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 GlaxoSmithKline Plc Recent Developments/Updates
  • 2.3 Novartis AG
    • 2.3.1 Novartis AG Details
    • 2.3.2 Novartis AG Major Business
    • 2.3.3 Novartis AG Inhaler Corticosteroid Device Product and Services
    • 2.3.4 Novartis AG Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novartis AG Recent Developments/Updates
  • 2.4 Mylan NV
    • 2.4.1 Mylan NV Details
    • 2.4.2 Mylan NV Major Business
    • 2.4.3 Mylan NV Inhaler Corticosteroid Device Product and Services
    • 2.4.4 Mylan NV Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Mylan NV Recent Developments/Updates
  • 2.5 Teva Pharmaceutical Industries Ltd.
    • 2.5.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.5.3 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product and Services
    • 2.5.4 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.6 Boehringer Ingelheim International GmbH
    • 2.6.1 Boehringer Ingelheim International GmbH Details
    • 2.6.2 Boehringer Ingelheim International GmbH Major Business
    • 2.6.3 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product and Services
    • 2.6.4 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
  • 2.7 AstraZeneca
    • 2.7.1 AstraZeneca Details
    • 2.7.2 AstraZeneca Major Business
    • 2.7.3 AstraZeneca Inhaler Corticosteroid Device Product and Services
    • 2.7.4 AstraZeneca Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 AstraZeneca Recent Developments/Updates
  • 2.8 F. Hoffmann-La Roche Ltd.
    • 2.8.1 F. Hoffmann-La Roche Ltd. Details
    • 2.8.2 F. Hoffmann-La Roche Ltd. Major Business
    • 2.8.3 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product and Services
    • 2.8.4 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
  • 2.9 Amgen Inc.
    • 2.9.1 Amgen Inc. Details
    • 2.9.2 Amgen Inc. Major Business
    • 2.9.3 Amgen Inc. Inhaler Corticosteroid Device Product and Services
    • 2.9.4 Amgen Inc. Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Amgen Inc. Recent Developments/Updates
  • 2.10 Aurobindo Pharma
    • 2.10.1 Aurobindo Pharma Details
    • 2.10.2 Aurobindo Pharma Major Business
    • 2.10.3 Aurobindo Pharma Inhaler Corticosteroid Device Product and Services
    • 2.10.4 Aurobindo Pharma Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Aurobindo Pharma Recent Developments/Updates
  • 2.11 Sumitomo Corporation
    • 2.11.1 Sumitomo Corporation Details
    • 2.11.2 Sumitomo Corporation Major Business
    • 2.11.3 Sumitomo Corporation Inhaler Corticosteroid Device Product and Services
    • 2.11.4 Sumitomo Corporation Inhaler Corticosteroid Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Sumitomo Corporation Recent Developments/Updates

3 Competitive Environment: Inhaler Corticosteroid Device by Manufacturer

  • 3.1 Global Inhaler Corticosteroid Device Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Inhaler Corticosteroid Device Revenue by Manufacturer (2018-2023)
  • 3.3 Global Inhaler Corticosteroid Device Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Inhaler Corticosteroid Device by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Inhaler Corticosteroid Device Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Inhaler Corticosteroid Device Manufacturer Market Share in 2022
  • 3.5 Inhaler Corticosteroid Device Market: Overall Company Footprint Analysis
    • 3.5.1 Inhaler Corticosteroid Device Market: Region Footprint
    • 3.5.2 Inhaler Corticosteroid Device Market: Company Product Type Footprint
    • 3.5.3 Inhaler Corticosteroid Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Inhaler Corticosteroid Device Market Size by Region
    • 4.1.1 Global Inhaler Corticosteroid Device Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Inhaler Corticosteroid Device Consumption Value by Region (2018-2029)
    • 4.1.3 Global Inhaler Corticosteroid Device Average Price by Region (2018-2029)
  • 4.2 North America Inhaler Corticosteroid Device Consumption Value (2018-2029)
  • 4.3 Europe Inhaler Corticosteroid Device Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Inhaler Corticosteroid Device Consumption Value (2018-2029)
  • 4.5 South America Inhaler Corticosteroid Device Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Inhaler Corticosteroid Device Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
  • 5.2 Global Inhaler Corticosteroid Device Consumption Value by Type (2018-2029)
  • 5.3 Global Inhaler Corticosteroid Device Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
  • 6.2 Global Inhaler Corticosteroid Device Consumption Value by Application (2018-2029)
  • 6.3 Global Inhaler Corticosteroid Device Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
  • 7.2 North America Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
  • 7.3 North America Inhaler Corticosteroid Device Market Size by Country
    • 7.3.1 North America Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
  • 8.2 Europe Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
  • 8.3 Europe Inhaler Corticosteroid Device Market Size by Country
    • 8.3.1 Europe Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Inhaler Corticosteroid Device Market Size by Region
    • 9.3.1 Asia-Pacific Inhaler Corticosteroid Device Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Inhaler Corticosteroid Device Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
  • 10.2 South America Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
  • 10.3 South America Inhaler Corticosteroid Device Market Size by Country
    • 10.3.1 South America Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Inhaler Corticosteroid Device Market Size by Country
    • 11.3.1 Middle East & Africa Inhaler Corticosteroid Device Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Inhaler Corticosteroid Device Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Inhaler Corticosteroid Device Market Drivers
  • 12.2 Inhaler Corticosteroid Device Market Restraints
  • 12.3 Inhaler Corticosteroid Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Inhaler Corticosteroid Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Inhaler Corticosteroid Device
  • 13.3 Inhaler Corticosteroid Device Production Process
  • 13.4 Inhaler Corticosteroid Device Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Inhaler Corticosteroid Device Typical Distributors
  • 14.3 Inhaler Corticosteroid Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Inhaler Corticosteroid Device market size was valued at USD 611.2 million in 2022 and is forecast to a readjusted size of USD 842.4 million by 2029 with a CAGR of 4.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Inhaler Corticosteroid Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Inhaler Corticosteroid Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Inhaler Corticosteroid Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Inhaler Corticosteroid Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Inhaler Corticosteroid Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Inhaler Corticosteroid Device
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Inhaler Corticosteroid Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV and Teva Pharmaceutical Industries Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Inhaler Corticosteroid Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Beclomethasone Dipropionate
    Budesonide
    Fluticasone Inhaler Powder
    Mometasone
    Market segment by Application
    Hospitals and Clinics
    Academic and Research Institutes
    Major players covered
    Pfizer Inc.
    GlaxoSmithKline Plc
    Novartis AG
    Mylan NV
    Teva Pharmaceutical Industries Ltd.
    Boehringer Ingelheim International GmbH
    AstraZeneca
    F. Hoffmann-La Roche Ltd.
    Amgen Inc.
    Aurobindo Pharma
    Sumitomo Corporation
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Inhaler Corticosteroid Device product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Inhaler Corticosteroid Device, with price, sales, revenue and global market share of Inhaler Corticosteroid Device from 2018 to 2023.
    Chapter 3, the Inhaler Corticosteroid Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Inhaler Corticosteroid Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Inhaler Corticosteroid Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Inhaler Corticosteroid Device.
    Chapter 14 and 15, to describe Inhaler Corticosteroid Device sales channel, distributors, customers, research findings and conclusion.

    Buy now